HRMY

37.27

2.36% 0.86

Handel nachbörslich: 37.27

Harmony Biosciences Holdings Inc (HRMY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HRMY? Forum Prognose

Schlusskurs vom Vortag:

$36.41

Offen:

$36.74

24-Stunden-Volumen:

516.60K

Relative Volume:

0.71

Marktkapitalisierung:

$2.15B

Einnahmen:

$772.53M

Nettoeinkommen (Verlust:

$180.90M

KGV:

12.01

EPS:

3.1024

Netto-Cashflow:

$258.73M

1W Leistung:

+2.05%

1M Leistung:

+1.41%

6M Leistung:

+7.50%

1J Leistung:

-3.89%

1-Tages-Spanne:

$36.16

$37.54

1-Wochen-Bereich:

$36.16

$38.37

52-Wochen-Spanne:

$25.52

$40.87

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Firmenname

Harmony Biosciences Holdings Inc

Sektor

Healthcare (1114)

Branche

Biotechnology (623)

Telefon

(484) 539-9800

Adresse

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Mitarbeiter

268

Twitter

Nächster Verdiensttermin

2024-10-29

Neueste SEC-Einreichungen

HRMY's Discussions on Twitter

Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HRMY Harmony Biosciences Holdings Inc	37.27	2.10B	772.53M	180.90M	258.73M	3.1024
VRTX Vertex Pharmaceuticals Inc	477.92	116.41B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	785.51	81.05B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	811.45	50.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	328.16	43.76B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	353.92	38.40B	4.98B	69.60M	525.67M	0.5198

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-21	Eingeleitet	Truist	Buy
2025-07-10	Fortgesetzt	Goldman	Neutral
2025-06-02	Fortgesetzt	Oppenheimer	Outperform
2025-02-11	Eingeleitet	Deutsche Bank	Buy
2024-12-17	Eingeleitet	H.C. Wainwright	Buy
2024-10-10	Fortgesetzt	Raymond James	Outperform
2024-09-10	Eingeleitet	UBS	Buy
2024-06-21	Eingeleitet	Citigroup	Buy
2024-01-02	Herabstufung	BofA Securities	Neutral → Underperform
2023-09-25	Herabstufung	Goldman	Neutral → Sell
2023-09-07	Eingeleitet	Berenberg	Buy
2023-04-20	Eingeleitet	BofA Securities	Neutral
2022-10-14	Hochstufung	Janney	Neutral → Buy
2022-10-14	Hochstufung	Jefferies	Hold → Buy
2022-08-03	Herabstufung	Jefferies	Buy → Hold
2022-07-13	Herabstufung	Goldman	Buy → Neutral
2022-07-07	Eingeleitet	Mizuho	Buy
2022-04-14	Eingeleitet	Cantor Fitzgerald	Overweight
2021-12-01	Eingeleitet	Oppenheimer	Outperform
2021-11-04	Eingeleitet	Raymond James	Outperform
2021-09-23	Eingeleitet	Needham	Buy
2021-03-29	Hochstufung	Goldman	Neutral → Buy
2020-09-14	Eingeleitet	Goldman	Neutral
2020-09-14	Eingeleitet	Jefferies	Buy
2020-09-14	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten

Feb 05, 2026

Zacks.com featured highlights include Harmony Biosciences, Adecoagro, Sociedad Quimica y Minera de Chile, Angi and PHINIA - The Globe and Mail

Feb 05, 2026

Movement Recap: Is AT T Inc forming a double bottom2025 Market Trends & Fast Gain Swing Alerts - baoquankhu1.vn

Feb 05, 2026

Feb 04, 2026

Zacks.com featured highlights include Harmony Biosciences, Universal Health Services, Concentrix and Global Payments - Yahoo Finance

Feb 02, 2026

CFO’s Full Share Exit Contrasts With Harmony’s Positive WAKIX Growth Story - Yahoo! Finance Canada

Feb 02, 2026

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2025 Earnings Call Transcript - MSN

Feb 02, 2026

Feb 01, 2026

Is Harmony Biosciences (HRMY) Pricing Reflect Its Cash Flow Potential After Recent Share Weakness - Sahm

Feb 01, 2026

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update - MarketBeat

Feb 01, 2026

Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity - AOL.com

Feb 01, 2026

Capital Management Corp VA Sells 29,654 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Feb 01, 2026

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Feb 01, 2026

Jan 31, 2026

Harmony Biosciences CFO Fully Exits Equity Ownership - intellectia.ai

Jan 31, 2026

Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800 - Yahoo Finance

Jan 31, 2026

Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800 - The Motley Fool

Jan 31, 2026

Jan 29, 2026

Is Harmony Biosciences (HRMY) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com

Jan 29, 2026

Hussman Strategic Advisors Inc. Reduces Stock Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Jan 29, 2026

Insider Sell: Sandip Kapadia Sells Shares of Harmony Biosciences Holdings Inc (HRMY) - GuruFocus

Jan 29, 2026

Jan 28, 2026

Sandip Kapadia Sells 3,746 Shares of Harmony Biosciences (NASDAQ:HRMY) Stock - MarketBeat

Jan 28, 2026

How Harmony Biosciences Can Prove Its Skeptics Wrong - Finviz

Jan 28, 2026

What’s the analyst consensus on Harmony Biosciences Holdings Inc.Earnings Beat & AI Powered Market Entry Ideas - Mfd.ru

Jan 28, 2026

Harmony Biosciences: Still Undervalued But Unappealing Risk/Reward (Downgrade) - Seeking Alpha

Jan 28, 2026

Jan 27, 2026

Is Harmony Biosciences (HRMY) Attractive After Recent Price Weakness And DCF Upside Potential? - Yahoo Finance

Jan 27, 2026

Evaluating Harmony Biosciences (HRMY) Valuation After Stronger Fundamentals And Breakout Signals - Yahoo Finance

Jan 27, 2026

Harmony Biosciences Holdings (HRMY) Investor Outlook: A Promising 24.34% Upside Potential - DirectorsTalk Interviews

Jan 27, 2026

Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? - Finviz

Jan 27, 2026